AA
Develops, manufactures, and markets radiopharmaceuticals for diagnostic and therapeutic applications.
About
Advanced Accelerator Applications (AAA) is a pharmaceutical company specializing in nuclear medicine, focusing on the development, manufacturing, and commercialization of radiopharmaceuticals for diagnostic and therapeutic purposes. Their products are used in oncology, neurology, cardiology, and infectious diseases.
Tags
Total Employees
628
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
54Traction
59Team
30Visibility
5Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Advanced Accelerator Applications do?
Advanced Accelerator Applications (AAA) is a pharmaceutical company specializing in nuclear medicine, focusing on the development, manufacturing, and commercialization of radiopharmaceuticals for diagnostic and therapeutic purposes. Their products are used in oncology, neurology, cardiology, and infectious diseases.
How much funding has Advanced Accelerator Applications raised?
Advanced Accelerator Applications has raised a total of $56M in funding. The most recent round on record is Grant (prize money).
Where is Advanced Accelerator Applications headquartered?
Advanced Accelerator Applications is headquartered in Saint-Genis-Pouilly, France.
When was Advanced Accelerator Applications founded?
Advanced Accelerator Applications was founded in 2002.
What industry does Advanced Accelerator Applications operate in?
Advanced Accelerator Applications operates in Pharmaceuticals, Biotechnology, Medical Devices, Oncology, Nuclear Medicine.
How many employees does Advanced Accelerator Applications have?
Advanced Accelerator Applications has approximately 628 people on record.
What is Advanced Accelerator Applications's current status?
Advanced Accelerator Applications's current operating status is: Acquired.
Similar Startups